Jaffetilchin Investment Partners »

Crispr Therapeutics shares owned by Jaffetilchin Investment Partners

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Jaffetilchin Investment Partners from 13F filings

Historical chart of Jaffetilchin Investment Partners investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Jaffetilchin Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Jaffetilchin Investment Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $205k 5.2k 39.36
2024-09-30 $156k 3.3k 46.98
2023-09-30 $225k 4.9k 45.39
2023-06-30 $232k 4.1k 56.14
2022-06-30 $215k 3.5k 60.77

More positions owned by Jaffetilchin Investment Partners

Ishares Core S&p Total U S Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Vanguard Total Stock Market Etf Etf (VTI)
Schwab U S Large-cap Etf Etf (SCHX)
Nvidia Corporation Stock (NVDA)
Vanguard Large-cap Etf Etf (VV)
Invesco Qqq Trust Series I Etf (QQQ)
State Street Spdr Portfolio S&p 1500 Composite Stock Market Etf Etf (SPTM)
Schwab U S Broad Market Etf Etf (SCHB)
Tesla Stock (TSLA)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Amazon Stock (AMZN)
Ft Vest Us Equity Deep Buffer Etf - January Etf (DJAN)
Ishares Treasury Floating Rate Bond Etf Etf (TFLO)

View all positions for Jaffetilchin Investment Partners

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics